Inhibitory Peptide of Mitochondrial μ-Calpain Protects against Photoreceptor Degeneration in Rhodopsin Transgenic S334ter and P23H Rats
Open Access
- 9 August 2013
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 8 (8) , e71650
Abstract
Mitochondrial μ-calpain and apoptosis-inducing factor (AIF)-dependent photoreceptor cell death has been seen in several rat and mouse models of retinitis pigmentosa (RP). Previously, we demonstrated that the specific peptide inhibitor of mitochondrial μ-calpain, Tat-µCL, protected against retinal degeneration following intravitreal injection or topical eye-drop application in Mertk gene-mutated Royal College of Surgeons rats, one of the animal models of RP. Because of the high rate of rhodopsin mutations in RP patients, the present study was performed to confirm the protective effects of Tat-µCL against retinal degeneration in rhodopsin transgenic S334ter and P23H rats. We examined the effects of intravitreal injection or topical application of the peptide on retinal degeneration in S334ter and P23H rats by terminal deoxynucleotidyl transferase-mediated dUTP nick-end labeling (TUNEL) assay, electroretinogram (ERG), immunohistochemistry for AIF, and histological staining. In S334ter rats, we found that intravitreal injection or topical application of the peptide prevented photoreceptor cell death from postnatal (PN) 15 to 18 days, the time of early-stage retinal degeneration. Topical application of the peptide also delayed attenuation of ERG responses from PN 28 to 56 days. In P23H rats, topical application of the peptide protected against photoreceptor cell death and nuclear translocation of AIF on PN 30, 40, and 50 days, as the primary stages of degeneration. We observed that topical application of the peptide inhibited the thinning of the outer nuclear layer and delayed ERG attenuations from PN 30 to 90 days. Our results demonstrate that the mitochondrial μ-calpain and AIF pathway is involved in early-stage retinal degeneration in rhodopsin transgenic S334ter and P23H rats, and inhibition of this pathway shows curative potential for rhodopsin mutation-caused RP.Keywords
This publication has 51 references indexed in Scilit:
- Oxidative modification sensitizes mitochondrial apoptosis-inducing factor to calpain-mediated processingFree Radical Biology and Medicine, 2010
- Mitochondrial m-calpain plays a role in the release of truncated apoptosis-inducing factor from the mitochondriaBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2009
- IRE1 Signaling Affects Cell Fate During the Unfolded Protein ResponseScience, 2007
- Apoptosis in retinal degeneration involves cross-talk between apoptosis-inducing factor (AIF) and caspase-12 and is blocked by calpain inhibitorsProceedings of the National Academy of Sciences, 2006
- Rhodopsin maturation defects induce photoreceptor death by apoptosis: a fly model for RhodopsinPro23His human retinitis pigmentosaHuman Molecular Genetics, 2005
- Photoreceptor Degeneration in Pro23His and S334ter Transgenic Rats2003
- P23H rhodopsin transgenic rat: correlation of retinal function with histopathology.2000
- Mutation of the receptor tyrosine kinase gene Mertk in the retinal dystrophic RCS ratHuman Molecular Genetics, 2000
- Functional heterogeneity of mutant rhodopsins responsible for autosomal dominant retinitis pigmentosa.Proceedings of the National Academy of Sciences, 1991
- A point mutation of the rhodopsin gene in one form of retinitis pigmentosaNature, 1990